Acute Coronary Syndrome: Pathophysiology, Diagnosis, and Management

Clinical Manifestations

In a STEMI, patients often report an abrupt onset of severe, unrelieved chest pain that may radiate to the jaw, shoulders, upper back, or arms. This is often accompanied by a systemic nervous system response, including:

• Gastrointestinal: Nausea and vomiting.
• Autonomic: Tachycardia, vasoconstriction, and diaphoresis.
• Psychological: Intense anxiety or a "feeling of impending doom".
• Hemodynamic: Hypotension, which may progress to cardiogenic shock (pump failure).

Diagnostic Evaluation

To differentiate between the types of ACS, clinicians rely on two primary tools: the Electrocardiogram (EKG) and serum biomarkers.

1. EKG Changes: The EKG provides a real-time view of electrical conduction through the heart tissue. STEMIs are identified by ST-segment elevation, indicating significant injury to the heart muscle.

2. Serum Biomarkers: When myocardial cells are damaged or die, they release specific proteins into the bloodstream.

• Troponin I and T: These are highly specific markers for cardiac injury and are the gold standard for diagnosing MI.
• Creatine Kinase (CK-MB): An enzyme that rises following myocardial damage.

Exam Tip: If a patient presents with chest pain and an EKG shows ST-segment elevation, it is a medical emergency requiring immediate reperfusion. If the EKG is non-diagnostic but Troponins are elevated, the diagnosis is likely NSTEMI.

Management and Reperfusion Therapies

The guiding principle in ACS management is "time is muscle"—the faster blood flow is restored, the more myocardium can be saved.

Immediate Pharmacologic Interventions

Initial treatment often includes:

• Antiplatelets: Such as Aspirin, to prevent further clot growth.
• Nitrates: To promote vasodilation and reduce preload.
• Anticoagulants: To prevent thrombus propagation.
• Beta-blockers: To reduce myocardial oxygen demand.

Reperfusion Strategies

Reperfusion is the process of re-establishing blood flow to the ischemic area.

• Percutaneous Coronary Intervention (PCI): This is a minimally invasive procedure involving balloon angioplasty and the placement of a stent to mechanically open the occluded artery.
• Thrombolytic Therapy: "Clot-busting" drugs used when PCI is not immediately available.
• Coronary Artery Bypass Graft (CABG): A surgical procedure where a healthy vessel is used to bypass the blocked segment of the coronary artery.

Post-Infarction Complications

Following an MI, the heart undergoes significant structural and functional changes. The area of damage is typically divided into three zones:

1. Necrotic Zone: The central area of dead tissue.
2. Surrounding Zone: Cells that are injured or hypoxic but may still recover.
3. Outer Ischemic Zone: Salvageable cells that are currently deprived of oxygen.

Over time, the necrotic area is replaced by granulation and eventually scar tissue. However, this process can lead to serious complications:

• Dysrhythmias and Arrhythmias: Electrical instability due to damaged tissue.
• Mechanical Failures: Such as ventricular or valve rupture.
• Heart Failure: Resulting from the loss of contractile function in the damaged muscle.
• Cardiogenic Shock: Severe pump failure leading to inadequate systemic perfusion.